Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-331

  1. 1,101 Posts.
    lightbulb Created with Sketch. 173
    I think there is an error in your calculation. 40 total patients with an average reduction of 14%, not 2 %.
    I won't read too much into the supposedly 'failure' of this trial due to a number of factors
    - small sample size
    - the trial is of very short duration- 6 months or so, the landmark trial for irbersartan (
    . 2001 Sep 20;345(12):870-8.
    doi: 10.1056/NEJMoa011489.)
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
45.5¢
Change
0.030(7.06%)
Mkt cap ! $254.5M
Open High Low Value Volume
43.0¢ 45.5¢ 43.0¢ $611.3K 1.370M

Buyers (Bids)

No. Vol. Price($)
1 5000 45.0¢
 

Sellers (Offers)

Price($) Vol. No.
45.5¢ 37575 2
View Market Depth
Last trade - 16.10pm 25/04/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.